GLPwatch
Papers (12034)
Page 158 of 201, ranked by citation count.
- 68Ga-NODAGA-Exendin-4 PET/CT Findings in a Case of Metastatic Insulinoma With Refractory Hypoglycemia Controlled by 90Y Transarterial Radioembolization.
- Liraglutide Attenuates Endothelial Dysfunction by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the LARP7/SIRT1 Pathway.
- Diabetes: Lixisenatide does not increase rates of CVD events.
- Semaglutide and Risk of Adult-Onset Seizure: A Target Trial Emulation.
- Lessons From LEADER - All-round Leadership.
- Cross-sectional analysis of the reliability and engagement metrics of YouTube videos on semaglutide for weight loss.
- Retatrutide.
- Semaglutide alleviates age-related dry eye disease by restoring lacrimal gland structure and function.
- Echoes of Dormancy: Anomic Aphasia Unveils Neurocysticercosis Reactivation in a Patient on Semaglutide.
- Real-world comparative outcomes of GLP-1 RA and semaglutide prescription among individuals with type 2 diabetes.
- [The GLP-1 analogue battle: effects of semaglutide 0,5 mg/weekly versus liraglutide 3 mg/daily on anthropometric parameters after 3 months in a real world-scenario].
- Effects of semaglutide, a GLP-1 receptor agonist, on food preferences in Japanese subjects with type 2 diabetes and visceral fat accumulation.
- [Treatment strategy for elderly diabetic patient with insulin or GLP-1 receptor agonist].
- <i>Akkermansia muciniphila</i> and GLP-1-Based Therapies: Bidirectional Interactions and Implications for Type 2 Diabetes and MASLD/MASH.
- Functional hydrophilic polystyrene beads with uniformly size and high cross-linking degree facilitated rapid separation of exenatide.
- Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes: Findings from PIONEER REAL India.
- Pharmacotherapy for obesity management.
- Association between semaglutide use and thyroid eye disease-related outcomes in autoimmune thyroiditis with type II diabetes.
- Fixing the food environment: beyond weight-loss drugs.
- Liraglutide Ameliorates Injury-Related Vascular Repair by Activating Autophagy Through Modulation of the PI3K-mTOR Signaling Pathway.
- Comparative Effects of Dulaglutide and Semaglutide on Renal Function Decline and Proteinuria Reduction in Diabetic Patients: A Retrospective Cohort Study.
- The FLOW of Progress in Diabetic Kidney Disease: Semaglutide's Role in Combination Therapy.
- Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovation.
- [Effects of exendin-4 on methylglyoxal-induced oxidative stress in PC12 cells].
- Media Coverage of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) After Semaglutide Use: A Content Analysis of News Reporting Accuracy and Framing.
- Assessment of noninferiority of oral vs subcutaneous semaglutide: a systematic review and meta-analysis.
- Effectiveness of GLP-1 RAs and SGLT2 inhibitors in preventing T2DM in high-risk patients: an updated systematic review and meta-analysis.
- Semaglutide Beyond Diabetes and Obesity: Systematic Review and Meta-Analysis of Multisystem Therapeutic Benefits.
- Endocrinology: What You May Have Missed in 2025.
- Tirzepatide for Lipodystrophy.
- Effects from treating moderate- to high-risk obesity patients with anti-obesity medication from a societal perspective.
- Glucagon-like peptide-1 stimulates acute secretion of pro-atrial natriuretic peptide from the isolated, perfused pig lung exposed to warm ischemia.
- Mechanisms of efficacy of drug therapy in type 2 diabetes: the role of microbiomes.
- Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta-Analysis of Randomized Clinical Trials.
- Extended-release exenatide (Bydureon) for type 2 diabetes.
- Worsening vasomotor symptoms in the setting of estradiol and semaglutide: a case report.
- Efficacy and safety of dapagliflozin and liraglutide in patients with type 2 diabetes mellitus and newly diagnosed as overweight/obese.
- Efficacy and Safety of Mazdutide in Managing Overweight and Obesity Among Non-Diabetic Adults: A Meta-Analysis of Randomised Controlled Trials.
- Low discontinuation rate of tirzepatide treatment in Japanese patients with diabetes mellitus; importance of traditional Japanese diet.
- Asymptomatic Subcutaneous Semaglutide Overdose: A Case Report and Literature Review.
- Time-Efficacy Relationship of Semaglutide in the Treatment of Type 2 Diabetes Mellitus: A Model-Based Meta-Analysis.
- Brachial Plexopathy Following Rapid Weight Loss from Tirzepatide: A Case Report.
- Depot-specific differences and heterogeneity of adipose-derived stem cells in diet-induced obesity.
- NICE approves liraglutide for diabetic patients not achieving glucose control.
- The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis.
- Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.
- Effect of ketogenic diet plus dulaglutide on glucose and lipid metabolism in diabetes mellitus.
- Tandem mass tag-based proteomic profiling revealed potential therapeutic targets and mechanisms of liraglutide for the treatment of impaired glucose tolerance.
- Real-World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non-Diabetic Adults.
- Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?
- Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes.
- Drug-induced liver injury secondary to tirzepatide.
- Once-weekly dulaglutide versus insulin glargine in the early control of fasting serum glucose and HbA1c.
- 2017 New Drug Update.
- Incretin Analogues for Weight Reduction in Non-Diabetic Obese: A Review of Liraglutide, Semaglutide, and Tirzepatide Beyond Glycemic Control.
- Effect of exenatide, pen insulin, and vial insulin on patient outcomes: a retrospective database analysis of persistence and first-year costs in a commercially insured population.
- Divergent effect of diabetes on fibrosis response to semaglutide and resmetirom in noncirrhotic MASH: A meta-analysis of randomized trials.
- An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 Diabetes.
- Comparison of IBD-related outcomes in patients with obesity treated with GLP-1 receptor agonists versus bariatric surgery.
- A cost-controlling treatment strategy of adding liraglutide to insulin in type 2 diabetes.